Regen BioPharma RGBP
OTC RGBP
$0.00 +0.00 (+0.00%)
At close: Sep 30, 2026 · 4:00 PM EDT

Regen BioPharma Inc (RGBP) Operating Income (2013 - 2025)

Updated

Regen BioPharma (RGBP) reported Operating Income of -$551,624 for fiscal Q1 2026 (quarter ended Dec 31, 2025), compared with -$61,378 a year earlier.

Analysis

Regen BioPharma Inc (RGBP) Operating Income (2013 - 2025) Analysis & Trends

Over the twelve months ended Dec 31, 2025, Regen BioPharma's Operating Income came in at -$828,784; for FY2025 (ended Sep 30, 2025), it was -$338,540.

  • By fiscal year, Operating Income came in at -$417,221 in FY2024, -$686,950 in FY2023, -$339,605 in FY2022 and -$200,771 in FY2021.
  • The fiscal Q1 2026 figure ranks as the lowest quarterly Operating Income since fiscal Q1 2018.
  • Per Business Quant data, the three fiscal quarters before Q1 2026 came in at -$123,055 (Q4 2025), -$40,756 (Q3 2025) and -$113,349 (Q2 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -551,624.00
Sep 30, 2025 -123,055.00
Jun 30, 2025 -40,756.00
Mar 31, 2025 -113,349.00
Dec 31, 2024 -61,378.00
Sep 30, 2024 -85,402.00
Jun 30, 2024 -107,966.00
Mar 31, 2024 -101,071.00
Dec 31, 2023 -122,782.00
Sep 30, 2023 -59,087.00
Jun 30, 2023 -85,155.00
Mar 31, 2023 -78,842.00
Dec 31, 2022 -463,867.00
Sep 30, 2022 -97,779.00
Jun 30, 2022 -58,910.00
Mar 31, 2022 -76,494.00
Dec 31, 2021 -106,422.00
Sep 30, 2021 -126,826.00
Jun 30, 2021 -42,491.00
Mar 31, 2021 -12,973.00
API Access

Regen BioPharma Inc Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=operating-income&ticker=RGBP&period=max&api_key=YOUR_API_KEY